GlaxoSmithKline
GSK
#291
Rank
NZ$116.73 B
Marketcap
$57.22
Share price
0.66%
Change (1 day)
-1.57%
Change (1 year)

EPS for GlaxoSmithKline (GSK)

EPS in 2023 (TTM): $5.67

According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $5.97. In 2022 the company made an earnings per share (EPS) of $14.45 an increase over its 2021 EPS that were of $5.10.

EPS history for GlaxoSmithKline from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$5.67-60.75%
2022$14.45183.39%
2021$5.10-17.83%
2020$6.2121.82%
2019$5.1023.91%
2018$4.11141.48%
2017$1.7064.6%
2016$1.03-90.64%
2015$11.05178.14%
2014$3.97-48.16%
2013$7.6722.63%
2012$6.25-11.32%
2011$7.05230.25%
2010$2.13-70.98%
2009$7.366.76%
2008$6.89-15.14%
2007$8.127.82%
2006$7.5319.61%
2005$6.3018.56%
2004$5.310.36%
2003$5.2950.39%
2002$3.5231.13%
2001$2.68-25.43%
2000$3.6031.58%
1999$2.731.05%
1998$2.71-0.98%
1997$2.73-10.07%
1996$3.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$3.38-43.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
$3.17-46.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.10-47.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.37 6.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$5.42-9.15%๐Ÿ‡ซ๐Ÿ‡ท France
-$3.41-157.13%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
$1.48-75.15%๐Ÿ‡บ๐Ÿ‡ธ USA